Sigma Healthcare (Sigma Healthcare) LT-Debt-to-Total-Asset : 0.09 (As of Jan. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sigma Healthcare's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.09.

Sigma Healthcare's long-term debt to total assets ratio declined from Jan. 2023 (0.18) to Jan. 2024 (0.09). It may suggest that Sigma Healthcare is progressively becoming less dependent on debt to grow their business.

Sigma Healthcare LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sigma Healthcare's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare LT-Debt-to-Total-Asset Chart

Sigma Healthcare Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.13

0.12

0.24

0.18

0.09

Sigma Healthcare Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.24	0.20	0.18	0.19	0.09

Sigma Healthcare LT-Debt-to-Total-Asset Calculation

Sigma Healthcare's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (A: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jan. 2024 )	/	Total Assets (A: Jan. 2024 )
	=	84.169	/	914.341
	=	0.09

Sigma Healthcare's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )	/	Total Assets (Q: Jan. 2024 )
	=	84.169	/	914.341
	=	0.09

Sigma Healthcare (OTCPK:SIGGF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sigma Healthcare LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma Healthcare (Sigma Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

S5YA:Germany SIG:Australia

Address

2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.sigmahealthcare.com.au

Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.